Skip to main content
. 2020 Jul 17;11:3584. doi: 10.1038/s41467-020-17414-y

Table 2.

Patients reporting any treatment emergent toxicities.

Grade 1 2 3 4 5
Arthralgia 2 (6%)
Anorexia 8 (24%) 2 (6%) 1 (3%)
Nausea 8 (24%) 2 (6%)
Diarrhea 7 (21%) 3 (9%)
Dysgeusia 4 (12%) 2 (6%)
Fatigue 6 (18%) 9 (27%) 2 (6%)
Hypothyroidism 1 (3%) 1 (3%)
Rash 2 (6%)
AST/ALT 2 (6%) 1 (3%) 3 (9%)
Thrombocytopenia 6 (18%) 4 (12%) 2 (6%)
Neutropenia 2 (6%) 1 (3%)
Hypophosphatemia 1 (3%) 1 (3%)
Hyponatremia 2 (6%)
Elevated creatinine 4 (12%) 2 (6%)
Pneumonitis 1 (3%)
Stroke 1 (3%)
Colitis^ 1 (3%)

^>30 days after removal from study.